Clinical trial
Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
NCT02922036 is registered in ClinicalTrials.gov with EBR Systems, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in Non-Responders, Previously Untreatable and High Risk Upgrade Patients (SOLVE CRT)
- Lead sponsor
- EBR Systems, Inc.
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- January 17, 2018
- Completion date
- June 30, 2026
- Enrollment
- 300 (estimated)
- Sites
- 68
Conditions
As the registry lists them; a condition with its own page is linked.